Home / Inspections / 1108572

FDA Inspection 1108572 — Astellas Pharma US Inc.

Astellas Pharma US Inc. — FEI 1000036852

The FDA completed an inspection of Astellas Pharma US Inc. on October 4, 2019 in Northbrook, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 4, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1217117 (OAI Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058496 (NAI Fri Jun 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030399 (NAI Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864055 (NAI Wed Feb 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 769358 (VAI Mon Feb 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources